Chemical formula: C₂₂H₃₆O₂ Molecular mass: 332.272 g/mol PubChem compound: 6918305
Ganaxolone is indicated for:
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Ganaxolone is indicated for the adjunctive treatment of epileptic seizures associated with cyclindependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 to 17 years of age. Ganaxolone may be continued in patients 18 years of age and older.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Ganaxolone is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
